Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SLBT
SLBT logo

SLBT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
SL Science Holding Ltd is a Taiwan-based company mainly engaged in the research and development (R&D) of cell and gene therapies for cancer treatment and regenerative medicine. The Company develops investigational immune cell technologies, including gamma delta (γδ) T cells, Armed-T cells and exosome-based formulations, and operates through its biotechnology and oncology research activities.
Show More

Events Timeline

No data

No data

News

Newsfilter
8.5
06-12Newsfilter
SL Bio Commences Trading on Nasdaq as SLBT
  • Business Combination Completed: SL Bio's merger with Horizon Space Acquisition II Corp. was finalized on June 12, 2026, resulting in an implied valuation of approximately $5.568 billion, marking a significant strategic expansion in the biomedical sector.
  • Funding for Innovative Therapies: The transaction includes a $7.8 million PIPE financing aimed at advancing SL Bio's proprietary Gamma delta T cell-based therapies, particularly for clinical trials targeting pancreatic and brain cancers, which is expected to significantly enhance treatment accessibility and efficiency.
  • Enhanced Executive Team: The leadership team of SL Bio has been strengthened with seasoned executives and independent directors, including CEO William Wang and CFO Ray Leung, ensuring effective compliance and driving business growth post-Nasdaq listing.
  • Global Market Access: Listing on Nasdaq provides SL Bio direct access to U.S. institutional capital markets, enhancing financial flexibility to attract top-tier global scientific talent and facilitate future strategic acquisitions and global licensing partnerships.
Wall Street analysts forecast SLBT stock price to rise
0 Analyst Rating
Wall Street analysts forecast SLBT stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for SL Science Holding Ltd (SLBT.O) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess SL Science Holding Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding SLBT

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is SL Science Holding Ltd (SLBT) stock price today?

The current price of SLBT is 0 USD — it has increased 0

What is SL Science Holding Ltd (SLBT)'s business?

SL Science Holding Ltd is a Taiwan-based company mainly engaged in the research and development (R&D) of cell and gene therapies for cancer treatment and regenerative medicine. The Company develops investigational immune cell technologies, including gamma delta (γδ) T cells, Armed-T cells and exosome-based formulations, and operates through its biotechnology and oncology research activities.

What is the price predicton of SLBT Stock?

Wall Street analysts forecast SLBT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLBT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SL Science Holding Ltd (SLBT)'s revenue for the last quarter?

SL Science Holding Ltd revenue for the last quarter amounts to NaN USD, decreased

What is SL Science Holding Ltd (SLBT)'s earnings per share (EPS) for the last quarter?

SL Science Holding Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does SL Science Holding Ltd (SLBT). have?

SL Science Holding Ltd (SLBT) has 0 emplpoyees as of June 13 2026.

What is SL Science Holding Ltd (SLBT) market cap?

Today SLBT has the market capitalization of 0.00 USD.